Detalhe da pesquisa
1.
Torin2 overcomes sorafenib resistance via suppressing mTORC2-AKT-BAD pathway in hepatocellular carcinoma cells.
Hepatobiliary Pancreat Dis Int;
19(6): 547-554, 2020 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33051131
2.
Impact of treatment modalities on patients with recurrent hepatocellular carcinoma after liver transplantation: Preliminary experience.
Hepatobiliary Pancreat Dis Int;
19(4): 365-370, 2020 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32553774
3.
Liver transplantation in a patient with massive polycystic liver disease.
Hepatobiliary Pancreat Dis Int;
19(2): 181-183, 2020 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32037279
4.
Clinical practice guidelines on liver transplantation for hepatocellular carcinoma in China (2018 edition).
Hepatobiliary Pancreat Dis Int;
18(4): 307-312, 2019 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31279679
5.
Gastrointestinal tract post-transplant lymphoproliferative disorder after liver transplantation.
Hepatobiliary Pancreat Dis Int;
16(5): 556-558, 2017 Oct 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28992890
6.
Kupffer cells contribute to concanavalin A-induced hepatic injury through a Th1 but not Th17 type response-dependent pathway in mice.
Hepatobiliary Pancreat Dis Int;
10(2): 171-8, 2011 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21459724
7.
The impact of miR-34a on protein output in hepatocellular carcinoma HepG2 cells.
Proteomics;
10(8): 1557-72, 2010 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20186752
8.
Multidisciplinary Treatment of Advanced Hepatocellular Carcinoma.
Case Rep Gastroenterol;
14(1): 98-102, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32231509
9.
Th17 promotes acute rejection following liver transplantation in rats.
J Zhejiang Univ Sci B;
11(11): 819-27, 2010 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21043049